Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: J Urol. 2016 Feb 9;195(6):1724–1730. doi: 10.1016/j.juro.2016.01.108

Figure 2.

Figure 2

Probability of generalized and prostate-cancer-specific anxiety over the initial surveillance period according to intolerance of uncertainty and urinary symptoms. Probabilities and p-values are derived from the repeated-measures multivariable models and are reported for the mean IUS score ± a half-standard deviation and urinary symptoms dichotomized into mild versus moderate/severe symptoms based on the IPSS.